Oragenics Inc. (OGEN)
NYSE · Healthcare
Oragenics Inc. EBITDA 2010–2023
Oragenics Inc. annual/quarterly ebitda history and growth rate from 2010 to 2023. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Oragenics Inc. ebitda for the quarter ending June 30, 2023 was -3.1 M, a 13.80% decrease year-over-year.
- Oragenics Inc. ebitda for the twelve months ending June 30, 2023 was -14.2 M, a 99.95% increase year-over-year.
- Oragenics Inc. annual ebitda for 2023 was -20.9 M, a 45.22% increase from 2022.
- Oragenics Inc. annual ebitda for 2022 was -14.4 M, a 8.61% decrease from 2021.
- Oragenics Inc. annual ebitda for 2021 was -15.7 M, a 136.45% increase from 2017.
- Oragenics Inc. annual ebitda for 2017 was -6.7 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Oragenics Inc. EBITDA — FAQ
Oragenics Inc. (OGEN) ebitda over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OGEN's ebitda history?
The chart and table above show Oragenics Inc.'s ebitda by year and by quarter, including the growth rate.